drug · small molecule
levosimendan
Phase 3updated 5mo agoby $TENX TENAX THERAPEUTICS, INC.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for congestive heart failure and cardiovascular disease and 12 investigational indications.
targets
Phosphodiesterase 3Troponin, cardiac muscle
all catalysts(0)
nothing on the calendar yet
Trials studying levosimendan
News(2)
- Novo shutters 2 more heart disease studies, indicating IL-6 is ‘invalid target’After the failure of Novo Nordisk’s IL-6 inhibitor ziltivekimab sent waves through the industry, the company has terminated two other studies of the asset, bringing the total number of high-profile…biospace · 26d ago
- STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal studyA Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.stat · 1mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that